PREVALENCE OF PELVIC INFLAMMATORY DISEASES IN PATIENTS WITH DIABETES MELLITUS
DOI:
https://doi.org/10.11603/mcch.2410-681X.2023.i4.14383Keywords:
pelvic inflammatory diseases, type 2 diabetes, cardiometabolic diseases, infertility, epidemiologyAbstract
Introduction. Studies have shown that women with a history of pelvic inflammatory disease had a significantly higher risk of developing hypertension and type 2 diabetes mellitus. The social significance of this group of pathologies lies in the reduction of fertility due to the development of serious complications, which leads to a decrease in the quality of life of patients.
In the study, scientific publications of recent years, which are available on the Internet, were processed, the key words were “pelvic inflammatory diseases” “diabetes mellitus”, “cardiometabolic diseases”, “endometritis”, “parametritis”, “salpingitis”, “oophoritis”.
Despite a relatively shorter duration of diabetes mellitus type 2 compared to women with type 1 diabetes, this patients are equally at risk for reproductive dysfunction, which may be related to comorbid obesity, polycystic ovary syndrome, and endogenous or exogenous hyperinsulinemia. It has been scientifically proven that, in addition to genital tract infections, diseases such as obesity, lipid metabolism disorders, and a history of abortion are also associated with an increased risk of infertility in pelvic organ disease (PID). The incidence of type 2 diabetes mellitus is also higher in women who have had a PID, while women with type 2 diabetes mellitus also have an increased risk of developing a PID. Moderate, significant statistical associations were found between urinary tract infection and PID, urinary tract infection, and diabetes. Infectious factors of PID can contribute to the development of cardiometabolic disorders through direct effects on the vascular system or indirect systemic effects of the response to infection.
The aim of the study – to analyze the frequency of distribution and features of the course of pelvic inflammatory diseases in patients with diabetes mellitus.
Conclusions. Analysis of the scientific literature indicates limited data on the epidemiology of pelvic inflammatory diseases and their association with diabetes mellitus.
References
WHO. (2019). Classification of diabetes mellitus. 2019. https://apps.who. int/iris/handle/10665/325182 (accessed May 15, 2023).
Chan, J.C.N., Lim, L.L., Wareham, N.J., Shaw, J.E., Orchard, T.J., Zhang, P., Lau, E.S.H., et al. (2021). The Lancet Commission on diabetes: using data to transform diabetes care and patient lives. Lancet (London, England), 396(10267), 2019-2082. https://doi.org/10. 1016/S0140-6736(20)32374-6
Cowie, C.C., Casagrande, S.S., Menke, A., Cissell, M.A., Eberhardt, M.S., Meigs, J.B., Gregg, E.W., et al. (Eds.). (2018). Diabetes in America. (3rd ed.). National Institute of Diabetes and Digestive and Kidney Diseases (US).International Diabetes Federation. IDF Diabetes Atlas, 10th edn. Brussels: International Diabetes Federation, 2021.
International Diabetes Federation. (2021). IDF Diabetes Atlas, 10th edn. Brussels: International Diabetes Federation.
Chatterjee, S., Khunti, K., & Davies, M.J. (2017). Type 2 diabetes. Lancet (London, England), 389(10085), 2239-2251. https://doi.org/10.1016/S0140-6736(17)30058-2
Magliano, D.J., Boyko, E.J. (2021). IDF diabetes atlas. Brussels: International Diabetes Federation © International Diabetes Federation.
Kahn, S.E., Cooper, M.E., & Del Prato, S. (2014). Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future. Lancet (London, England), 383(9922), 1068-1083. https://doi.org/10.1016/S0140-6736(13)62154-6
Baena-Díez, J. M., Peñafiel, J., Subirana, I., Ramos, R., Elosua, R., Marín-Ibañez, A., Guembe, M.J., et al, … FRESCO Investigators (2016). Risk of Cause-Specific Death in Individuals with Diabetes: A Competing Risks Analysis. Diabetes Care, 39(11), 1987-1995. https://doi.org/10.2337/dc16-0614
Tancredi, M., Rosengren, A., Svensson, A.M., Kosiborod, M., Pivodic, A., Gudbjörnsdottir, S., Wedel, H., Clements, M., Dahlqvist, S., & Lind, M. (2015). Excess Mortality among Persons with Type 2 Diabetes. The New England Journal of Medicine, 373(18), 1720-1732. https://doi.org/10.1056/NEJMoa1504347
Okoth, K., Thomas, G.N., Nirantharakumar, K., & Adderley, N.J. (2023). Risk of cardiometabolic outcomes among women with a history of pelvic inflammatory disease: a retrospective matched cohort study from the UK. BMC Women’s Health, 23(1), 80. https://doi.org/10. 1186/s12905-023-02214-5
Kornatska, A.H., Vovk, I.B., Chubei, H.V. (2012). Pelvic inflammatory diseases caused by sexually transmitted infections. Zdorovia Ukrainy, 4, 38-39 [in Ukrainian].
Benfield, T., Jensen, J.S., & Nordestgaard, B.G. (2007). Influence of diabetes and hyperglycaemia on infectious disease hospitalisation and outcome. Diabetologia, 50(3), 549-554. https://doi.org/10.1007/s00125-006-0570-3
Thong, E.P., Codner, E., Laven, J.S.E., & Teede, H. (2020). Diabetes: a metabolic and reproductive disorder in women. The Lancet. Diabetes & Endocrinology, 8(2), 134-149 https://doi.org/10.1016/S2213-8587(19)30345-6
Chiou, W.Y., Chen, C.A., Lee, M.S., Lin, H.Y., Li, C.Y., Su, Y.C., Tsai, S.J., & Hung, S.K. (2016). Pelvic inflammatory disease increases the risk of a second primary malignancy in patients with cervical cancer treated by surgery alone. Medicine, 95(47), e5409. https://doi.org/10.1097/MD.0000000000005409
Poeta do Couto, C., Policiano, C., Pinto, F. J., Brito, D., & Caldeira, D. (2023). Endometriosis and cardiovascular disease: A systematic review and meta-analysis. Maturitas, 171, 45-52. https://doi.org/10.1016/j.maturitas.2023.04.001
Liou, T.H., Wu, C.W., Hao, W.R., Hsu, M.I., Liu, J.C., & Lin, H.W. (2013). Risk of myocardial infarction in women with pelvic inflammatory disease. International Journal of Cardiology, 167(2), 416-420. https://doi.org/10. 1016/j.ijcard.2012.01.006
Chen, P.C., Tseng, T.C., Hsieh, J.Y., & Lin, H.W. (2011). Association between stroke and patients with pelvic inflammatory disease: a nationwide population-based study in Taiwan. Stroke, 42(7), 2074-2076. https://doi.org/10.1161/STROKEAHA.110.612655
Libby, P., & Ridker, P.M. (2004). Inflammation and atherosclerosis: role of C-reactive protein in risk assessment. The American Journal of Medicine, 116 Suppl 6A, 9S–16S. https://doi.org/10.1016/j.amjmed. 2004.02.006
Prasad, A., Zhu, J., Halcox, J.P., Waclawiw, M.A., Epstein, S.E., & Quyyumi, A.A. (2002). Predisposition to atherosclerosis by infections: role of endothelial dysfunction. Circulation, 106(2), 184-190. https://doi.org/10. 1161/01.cir.0000021125.83697.21
Azizia, M.M., Irvine, L.M., Coker, M., & Sanusi, F.A. (2006). The role of C-reactive protein in modern obstetric and gynecological practice. Acta obstetricia et gynecologica Scandinavica, 85(4), 394-401. https://doi.org/10. 1080/00016340500432614
Chase, H.P., Cooper, S., Osberg, I., Stene, L.C., Barriga, K., Norris, J., Eisenbarth, G.S., & Rewers, M. (2004). Elevated C-reactive protein levels in the development of type 1 diabetes. Diabetes, 53(10), 2569-2573. https://doi.org/10.2337/diabetes.53.10.2569
Hu, F.B., Meigs, J.B., Li, T.Y., Rifai, N., & Manson, J.E. (2004). Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes, 53(3), 693-700. https://doi.org/10.2337/diabetes.53.3.693
Wolf, M., Sandler, L., Hsu, K., Vossen-Smirnakis, K., Ecker, J.L., & Thadhani, R. (2003). First-trimester C-reactive protein and subsequent gestational diabetes. Diabetes Care, 26(3), 819-824. https://doi.org/10. 2337/diacare.26.3.819
Qiu, C., Sorensen, T.K., Luthy, D.A., & Williams, M.A. (2004). A prospective study of maternal serum C-reactive protein (CRP) concentrations and risk of gestational diabetes mellitus. Paediatric and Perinatal Epidemiology, 18(5), 377-384. https://doi.org/10.1111/ j.1365-3016.2004.00578.x
Arshiya, Sultana, Sumbul, Mehdi, Khaleequr, Rahman, M. J. A. Fazmiya, Md Belal Bin Heyat, Faijan, Akhtar, Atif, Amin Baig. (2022). Recent advancements of pelvic inflammatory disease: A review on evidence-based medicine. Computational Intelligence in Healthcare Applications, 7, 101-120.
Hida, M., Anno, T., Kawasaki, F., Kaneto, H., Kaku, K., & Okimoto, N. (2018). A rare case of large pyosalpinx in an elderly patient with well-controlled type 2 diabetes mellitus: a case report. Journal of Medical Case Reports, 12(1), 286. https://doi.org/10.1186/s13256-018-1841-6
Mitchell, C., & Prabhu, M. (2013). Pelvic inflammatory disease: current concepts in pathogenesis, diagnosis and treatment. Infectious disease clinics of North America, 27(4), 793-809. https://doi.org/10.1016/j.idc.2013.08.004
Curry, A., Williams, T., & Penny, M.L. (2019). Pelvic Inflammatory Disease: Diagnosis, Management, and Prevention. American Family Physician, 100(6), 357-364.
Brun, J.L., Castan, B., de Barbeyrac, B., Cazanave, C., Charvériat, A., Faure, K., Mignot, S., Verdon, R., Fritel, X., Graesslin, O., CNGOF, & SPILF (2020). Pelvic inflammatory diseases: Updated French guidelines. Journal of Gynecology Obstetrics and Human Reproduction, 49(5), 101714. https://doi.org/10.1016/j.jogoh.2020.101714
Brunham, R.C., Gottlieb, S.L., & Paavonen, J. (2015). Pelvic inflammatory disease. The New England Journal of Medicine, 372(21), 2039-2048. https://doi.org/10.1056/NEJMra1411426
Ruggeri, M., Cannas, S., Cubeddu, M., Molicotti, P., Piras, G. L., Dessole, S., & Zanetti, S. (2016). Bacterial agents as a cause of infertility in humans. The New Microbiologica, 39(3), 206-209.
Chayachinda, C., & Rekhawasin, T. (2017). Reproductive outcomes of patients being hospitalised with pelvic inflammatory disease. Journal of Obstetrics and Gynaecology: The Journal of the Institute of Obstetrics and Gynaecology, 37(2), 228-232. https://doi.org/10.1080/01443615.2016.1234439
Sleha, R., Boštíková, V., Salavec, M., Mosio, P., Kusáková, E., Kukla, R., Mazurová, J., & Spliňo, M. (2013). Bakteriální infekce jako příčina neplodnosti u lidí [Bacterial infection as a cause of infertility in humans]. Epidemiologie, mikrobiologie, imunologie: casopis Spolecnosti pro epidemiologii a mikrobiologii Ceske lekarske spolecnosti J.E. Purkyne, 62(1), 26-32.
Tsevat, D.G., Wiesenfeld, H.C., Parks, C., & Peipert, J.F. (2017). Sexually transmitted diseases and infertility. American journal of obstetrics and gynecology, 216(1), 1-9. https://doi.org/10.1016/j.ajog.2016. 08.008
Park, S.T., Lee, S.W., Kim, M.J., Kang, Y.M., Moon, H.M., & Rhim, C.C. (2017). Clinical characteristics of genital chlamydia infection in pelvic inflammatory disease. BMC Women's Health, 17(1), 5. https://doi.org/10.1186/s12905-016-0356-9
Park, H.J., Kim, Y.S., Yoon, T.K., & Lee, W.S. (2016). Chronic endometritis and infertility. Clinical and experimental reproductive medicine, 43(4), 185-192. https://doi.org/10.5653/cerm.2016.43.4.185
Taylor, B.D., Darville, T., & Haggerty, C.L. (2013). Does bacterial vaginosis cause pelvic inflammatory disease? Sexually transmitted diseases, 40(2), 117-122. https://doi.org/10.1097/OLQ.0b013e31827c5a5b
Salah, R. M., Allam, A. M., Magdy, A. M., & Mohamed, A. S.h (2013). Bacterial vaginosis and infertility: cause or association? European journal of obstetrics, gynecology, and reproductive biology, 167(1), 59-63. https://doi.org/10.1016/j.ejogrb.2012.10.031
van Oostrum, N., De Sutter, P., Meys, J., & Verstraelen, H. (2013). Risks associated with bacterial vaginosis in infertility patients: a systematic review and meta-analysis. Human reproduction (Oxford, England), 28(7), 1809-1815. https://doi.org/10.1093/humrep/det096
Darwish, A.M., AbdelAleem, М.А., Agban, M.N., Mohamed, М.А. (2015). Laparoscopic and bacteriologic evidence of bacterial vaginosis in unexplained infertility. Int. J. Reprod. Contracept. Obstet. Gynecol., 4, 173-178.
Kreisel, K., Torrone, E., Bernstein, K., Hong, J., & Gorwitz, R. (2017). Prevalence of Pelvic Inflammatory Disease in Sexually Experienced Women of Reproductive Age - United States, 2013-2014. MMWR. Morbidity and mortality weekly report, 66(3), 80-83. https://doi.org/10. 15585/mmwr.mm6603a3
Yusuf, H., Trent, M. (2020). Pelvic Inflammatory Disease in Adolescents. In: Reference Module in Biomedical Sciences. Elsevier.
CDC. (2022). Pelvic Inflammatory Disease (PID) – STI treatment guidelines. Available from: https://www.cdc.gov/std/treatment-guidelines/pid.htm. Accessed February 28, 2022
Anyalechi, G.E., Hong, J., Kreisel, K., Torrone, E., Boulet, S., Gorwitz, R., Kirkcaldy, R.D., & Bernstein, K. (2019). Self-Reported Infertility and Associated Pelvic Inflammatory Disease Among Women of Reproductive Age-National Health and Nutrition Examination Survey, United States, 2013-2016. Sexually transmitted diseases, 46(7), 446-451. https://doi.org/10.1097/OLQ.0000000000000996
Smith, J., Daley, F. C., Shakur, A., Addley, H.C., Moyle, P.L., Freeman, S. (2018). Causes and complications of female pelvic inflammatory disease: a multimodal imaging review. ECR.
Paul, A. (2011). Bourne, Urinary tract infections, pelvic inflamatory disease, hepatitis b, and diabetes mellitus among women of the reproductive ages in a developing nation. Journal of Clinical and Diagnostic Research, 5(2), 331–339.
Talmor, A., & Dunphy, B. (2015). Female obesity and infertility. Best practice & research. Clinical obstetrics & gynaecology, 29(4), 498-506. https://doi.org/10.1016/j.bpobgyn.2014.10.014
Klenov, V.E., & Jungheim, E.S. (2014). Obesity and reproductive function: a review of the evidence. Current opinion in obstetrics & gynecology, 26(6), 455-460. https://doi.org/10.1097/GCO.0000000000000113
Verit, F.F., Yildiz Zeyrek, F., Zebitay, A.G., & Akyol, H. (2017). Cardiovascular risk may be increased in women with unexplained infertility. Clinical and experimental reproductive medicine, 44(1), 28-32. https://doi.org/10.5653/cerm.2017.44.1.28
Agenor, A., & Bhattacharya, S. (2015). Infertility and miscarriage: common pathways in manifestation and management. Women's health (London, England), 11(4), 527-541. https://doi.org/10.2217/whe.15.19
Kreisel, K.M., Llata, E., Haderxhanaj, L., Pearson, W.S., Tao, G., Wiesenfeld, H.C., & Torrone, E.A. (2021). The Burden of and Trends in Pelvic Inflammatory Disease in the United States, 2006-2016. The Journal of infectious diseases, 224(12 Suppl. 2), S103-S112. https://doi.org/10.1093/infdis/jiaa771
Davis, G.S., Horner, P.J., Price, M.J., Mitchell, H.D., & Soldan, K. (2021). What Do Diagnoses of Pelvic Inflammatory Disease in Specialist Sexual Health Services in England Tell Us About Chlamydia Control?. The Journal of infectious diseases, 224(12 Suppl 2), S113-S120. https://doi.org/10.1093/infdis/jiab175
Chan, G.M.F., Fong, Y.F., & Ng, K.L. (2019). Tubo-Ovarian Abscesses: Epidemiology and Predictors for Failed Response to Medical Management in an Asian Population. Infectious diseases in obstetrics and gynecology, 2019, 4161394. https://doi.org/10.1155/ 2019/4161394
Brady, P. C. (2016) Handbook of consult and inpatient gynecology. Pelvic inflammatory disease and Tubo-ovarian abscesses. Springer, Berlin, 121-133. https://doi.org/10.1007/978-3-319-27724-0_
Burka, O.A., Tutchenko, T.M., Pedachenko, N.Iu., Kudlai, O.M. (2020). Suchasni pidkhody do vyboru antybakterialnykh preparativ pry zapalnykh protsesakh tazovykh orhaniv: rol innovatsiinykh mikrobiolohichnykh metodiv ohliad literatury. [Modern approaches to the selection of antibacterial drugs in inflammatory processes of the pelvic organs: the role of innovative microbiological methods, a review of the literature]. Reprodukt. endokrynol., 1(51), 25-31. https://doi.org/10.18370/2309-4117.2020.51.25-31. [in Ukrainian].
Goller, J.L., De Livera, A.M., Fairley, C.K., Guy, R.J., Bradshaw, C.S., Chen, M.Y., & Hocking, J.S. (2017). Characteristics of pelvic inflammatory disease where no sexually transmitted infection is identified: a cross-sectional analysis of routinely collected sexual health clinic data. Sexually transmitted infections, 93(1), 68-70. https://doi.org/10.1136/sextrans-2016-052553
Sweeney, S., Bateson, D., Fleming, K., & Huston, W. (2022). Factors associated with pelvic inflammatory disease: A case series analysis of family planning clinic data. Women's health (London, England), 18, 17455057221112263. https://doi.org/10.1177/ 17455057221112263
Taylor, B.D., Darville, T., & Haggerty, C.L. (2013). Does bacterial vaginosis cause pelvic inflammatory disease? Sexually transmitted diseases, 40(2), 117–122. https://doi.org/10.1097/OLQ.0b013e31827c5a5b
Epstein, S.E., Zhou, Y.F., & Zhu, J. (1999). Infection and atherosclerosis: emerging mechanistic paradigms. Circulation, 100(4), e20-e28. https://doi.org/10.1161/01.cir.100.4.e20
Tseng, C.H., Muo, C.H., Lin, M.C., & Kao, C.H. (2016). Association Between Reduced Risk of Intracerebral Hemorrhage and Pelvic Inflammatory Disease. Medicine, 95(5), e2726. https://doi.org/10.1097/MD. 0000000000002726
Mason, J.C., & Libby, P. (2015). Cardiovascular disease in patients with chronic inflammation: mechanisms underlying premature cardiovascular events in rheumatologic conditions. European heart journal, 36(8), 482-489c. https://doi.org/10.1093/eurheartj/ehu403
Okoth, K., Wang, J., Zemedikun, D., Thomas, G.N., Nirantharakumar, K., & Adderley, N.J. (2021). Risk of cardiovascular outcomes among women with endometriosis in the United Kingdom: a retrospective matched cohort study. BJOG : an international journal of obstetrics and gynaecology, 128(10), 1598-1609. https://doi.org/10.1111/1471-0528.16692
Schoenfeld, S.R., Kasturi, S., & Costenbader, K.H. (2013). The epidemiology of atherosclerotic cardiovascular disease among patients with SLE: a systematic review. Seminars in arthritis and rheumatism, 43(1), 77-95. https://doi.org/10.1016/j.semarthrit.2012.12.002
Lazzerini, P.E., Capecchi, P.L., & Laghi-Pasini, F. (2017). Systemic inflammation and arrhythmic risk: lessons from rheumatoid arthritis. European heart journal, 38(22), 1717-1727. https://doi.org/10.1093/eurheartj/ehw208
Sovari A.A. (2016). Cellular and Molecular Mechanisms of Arrhythmia by Oxidative Stress. Cardiology research and practice, 2016, 9656078. https://doi.org/10.1155/2016/9656078
Vonderlin, N., Siebermair, J., Kaya, E., Köhler, M., Rassaf, T., & Wakili, R. (2019). Critical inflammatory mechanisms underlying arrhythmias. Zugrundeliegende inflammtorische Mechanismen bei Herzrhythmusstörungen. Herz, 44(2), 121-129. https://doi.org/10.1007/s00059-019-4788-5
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Medical and Clinical Chemistry
This work is licensed under a Creative Commons Attribution 4.0 International License.
